Marjorie Taylor Greene
Marjorie Taylor Greene (R-GA) bought $1K-$15K of $ADBE (Adobe Inc. - Common Stock) on Jun 6, 2025, part of 8 transactions in this filing.
HillSignal flagged 3 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
3 flagsRep. Marjorie Taylor Greene bought $1,001 - $15,000 in $GILD on June 6, 2025 — 90 days before HR5127 ("PrEP and PEP are Prevention Act") was introduced, a bill that could increase demand for HIV prevention drugs.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Government Securities | US Treasury Bill(Government Securities) | $100K-$250K | — | — | — | Jun 12, 2025 |
| BUY | $ADBE | Adobe Inc. - Common Stock | $1K-$15K | $416.92 | — | — | Jun 6, 2025 |
| BUY | $AMAT | Applied Materials, Inc. - Common Stock | $1K-$15K | $166.74 | — | — | Jun 6, 2025 |
| BUY | $GILD | Gilead Sciences, Inc. - Common Stock | $1K-$15K | $112.46 | — | — | Jun 6, 2025 |
| BUY | $NFLX | Netflix, Inc. - Common Stock | $1K-$15K | $124.15 | — | — | Jun 6, 2025 |
| BUY | $NEE | NextEra Energy, Inc. Common Stock | $1K-$15K | $72.16 | — | — | Jun 6, 2025 |
| BUY | $NOW | ServiceNow, Inc. Common Stock | $1K-$15K | $206.04 | — | — | Jun 6, 2025 |
| BUY | $SNOW | Snowflake Inc. Class A Common Stock | $1K-$15K | $210.84 | — | — | Jun 6, 2025 |
Connected Legislative Activity
7 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PrEP and PEP are Prevention Act
The PrEP and PEP are Prevention Act (HR5127) mandates zero-cost coverage of HIV prevention drugs and associated lab monitoring across all US insurance programs. This early-stage bipartisan bill creates direct volume upside for Gilead ($GILD) on branded PrEP, Viatris ($VTRS) on generic PrEP, and Labcorp ($LH) on mandatory diagnostic services. Merck ($MRK) is excluded from the causal chain because its islatravir candidate is not FDA-approved and the bill only covers approved drugs.
Strengthening Agency Management and Oversight of Software Assets Act
HR2417 is an early-stage authorization bill requiring federal agencies to inventory and manage software assets. No new money is appropriated. The bill is stuck in committee with no floor schedule. Real market data shows Oracle ($ORCL) down 6.34% in 7 days to $162.30, ServiceNow ($NOW) down 4.08% in 7 days and 17.27% in 30 days to $86.49 — these moves are unrelated to this dormant procedural bill.
Lowering Broadband Costs for Consumers Act of 2025
HR4032 (Lowering Broadband Costs for Consumers Act) is an early-stage bill that would expand USF contribution requirements to broadband and edge providers. It remains in committee with no floor action, making near-term market impact negligible. If passed, $CMCSA, $T, $VZ, $GOOGL, $META, $AMZN, and $NFLX would face new recurring costs reducing segment margins by an estimated 1-3%.
Small Biotech Innovation Act
The Small Biotech Innovation Act (HR3731) is an early-stage bill that would exempt R&D-intensive small biotech manufacturers (≤5 qualifying drugs) from Medicare drug price negotiations starting in 2029. The bill is in committee with no floor action, and no market reaction is evident from provided data. The legislative path is long and uncertain — this is a structural watch item, not a trading catalyst.
Providing Veterans Essential Medications Act
HR1970 (Providing Veterans Essential Medications Act) is in early legislative stages, having been referred to the House Veterans' Affairs subcommittee. The bill mandates VA reimbursement for high-cost medications dispensed to veterans in State nursing homes, but authorizes no specific funding and remains months from passage. Real market data shows CVS up 16% in 30 days while CAH is down 10%, reflecting broader distribution-sector dynamics rather than this early-stage bill.
BRAIN Act
The BRAIN Act (HR2767) is an early-stage bill in the 119th Congress that authorizes no funding and has been referred to committee. Near-term market impact is negligible. The bill creates programmatic structures for brain tumor research, biospecimen transparency, and biomarker testing awareness, but actual market effects require future appropriations and bill text clarity. No publicly traded companies face material revenue exposure at this stage.
Content Origin Protection and Integrity from Edited and Deepfaked Media Act of 2025
S. 1396 (Content Origin Protection Act) is an early-stage bill requiring content provenance labeling for AI-generated content. It has not advanced beyond committee since April 2025 and carries no authorized funding. Adobe ($ADBE) is structurally positioned as a beneficiary if the bill gains momentum due to its existing C2PA/Content Credentials alignment, but the legislative path is long and uncertain. Major platform operators (GOOGL, META, MSFT, AMZN) face compliance costs that are immaterial relative to their scale.
Other Filings by Marjorie Taylor Greene
Free — no credit card
Get the next Greene trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.